Hologic (HOLX) to Report Q2 Earnings: What’s in the Cards?
ZacksStrength in Molecular Diagnostics business and GYN Surgical is likely to have driven Hologic’s (HOLX) fiscal second-quarter performance.
Strength in Molecular Diagnostics business and GYN Surgical is likely to have driven Hologic’s (HOLX) fiscal second-quarter performance.